Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions:  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  Drug: Eribulin Mesylate;  Other:Â...
Source: ClinicalTrials.gov - August 16, 2006 Category: Research Source Type: clinical trials
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions:  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  Drug: Eribulin Mesylate;  Other:Â...
Source: ClinicalTrials.gov - August 16, 2006 Category: Research Source Type: clinical trials
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions:  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  Drug: Eribulin Mesylate;  Other:Â...
Source: ClinicalTrials.gov - August 16, 2006 Category: Research Source Type: clinical trials
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions:  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  Drug: Eribulin Mesylate;  Other:Â...
Source: ClinicalTrials.gov - August 16, 2006 Category: Research Source Type: clinical trials
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions:  Distal Urethral Cancer;  Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;  Proximal Urethral Cancer;  Recurrent Bladder Cancer;  Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;  Recurrent Urethral Cancer;  Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Stage IV Urethral Cancer;  Ureter Cancer;  Urethral Cancer Associated With Invasive Bladder CancerInterventions:  Drug: eribulin mesylate;  Other: laboratory biomarkerÂ...
Source: ClinicalTrials.gov - August 16, 2006 Category: Research Source Type: clinical trials
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
Conditions:  Adenocarcinoma of the Bladder;  Distal Urethral Cancer;  Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;  Proximal Urethral Cancer;  Recurrent Bladder Cancer;  Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;  Recurrent Urethral Cancer;  Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;  Squamous Cell Carcinoma of the Bladder;  Stage III Bladder Cancer;  Stage IV Bladder Cancer;  Transitional Cell Carcinoma of the Bladder;  Urethral Cancer Associated With Invasive Bladder CancerInterventions:  Drug: ...
Source: ClinicalTrials.gov - June 2, 2005 Category: Research Source Type: clinical trials
